Phase IB assessment shows progression-free survival in patients with triple-negative breast cancer, indicating potential treatment efficacy.
Efficacy results. A, Kaplan–Meier (KM) curve and (B) swimmer plot displaying PFS time for the efficacy population (N = 23). C, Waterfall plot showing the best overall response for the 16 patients with measurable disease. The mutational status of the most frequently mutated genes in TNBC is shown underneath the waterfall plot. D, Spider plot of the efficacy population.
No takes yet. Share an insight, caveat, or question.
Manso et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: